G
$ Value
$0
Shares
49,754
Price
$0
Filed
Sep 11
Insider
Name
Dugel Pravin
Title
See Remarks
CIK
0001700917
Roles
Director
Officer
Transaction Details
Transaction Date
2025-09-09
Code
G
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
49,754
Footnotes
On September 9, 2025, the reporting person transferred 49,754 shares to his spouse for no consideration.
Filing Info
Dugel Pravin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-09 | OCUL | G | $0 |
| 2026-04-09 | OCUL | G | $0 |
| 2026-02-23 | OCUL | ▼ | $166K |
| 2026-02-12 | OCUL | ▼ | $1.1M |
| 2025-11-26 | OCUL | G | $0 |
| 2025-11-26 | OCUL | G | $0 |
| 2025-11-24 | OCUL | ▼ | $235K |
| 2025-09-09 | OCUL | G | $0 |
| 2025-09-09 | OCUL | G | $0 |
| 2025-08-25 | OCUL | ▼ | $259K |
Other Insiders at OCUL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LINDSTROM RICHARD L MD | $461K | — | 2026-02-20 |
|
Heier Jeffrey S.
Chief Scientific Officer
|
— | $25K | 2026-02-23 |
|
Dugel Pravin
See Remarks
|
— | $1.3M | 2026-04-09 |
|
Notman Donald
Chief Operating Officer
|
— | $205K | 2026-02-12 |
|
Kaiser Peter
Chief Development Officer
|
— | $23K | 2026-02-23 |
|
Nayak Sanjay
Chief Strategy Officer
|
— | $108K | 2026-02-23 |
|
Waheed Nadia
Chief Medical Officer
|
— | $98K | 2026-02-20 |
|
Robinson David Wayne
Global CCO
|
— | — | 2026-01-21 |